BRIEF-Sumitomo Pharma Co Ltd - Sumitomo Pharma America Announces Enzomenib (Dsp-5336) Receives FDA Breakthrough Therapy Designation For Treatment Of R/R Kmt2a-Rearranged Acute Leuke

Reuters · 5d ago

Please log in to view news